On the morning of June 13, 2024, Japan Vietnam Medical Investment And Development JSC (hose: JVC) successfully organized the 2024 Annual General Meeting of Shareholders at the 8th floor Hall, VNCC Building, No. 243 De La Thanh, Ward Lang Thuong, Dong Da District, Hanoi. The General Meeting approved JVC's strategic orientation for the period 2024 - 2028.

Looking back at 2023, with the great efforts of the Board of Directors and all employees, JVC has completed a number of important tasks such as:

• The company has taken advantage of market opportunities, implemented synchronous solutions, continued to promote its strengths in product lines, traditional business activities such as imaging equipment and consumables, associated business activities, technical services, and seek to develop new products.
• The company has built a lean and efficient apparatus, reviewed and controlled, saving costs in management and administration.
• JVC's profit after tax in 2023 reached VND 52.6 billion.
• In 2023, the Company invested VND 43.3 billion to purchase fixed assets for business activities.
• Revenue from financial activities reached 24.1 billion VND mainly from bond investment activities, profits from financial investment cooperation contracts, deposit interest, and exchange rate differences.

Strategic Orientation 2024 – 2028

JVC Board of Directors sets a goal of breakthrough revenue growth, sustainable profits over the years, diversifying more products while promoting advantages with traditional products. In parallel, JVC gradually transformed into a trade-service company by providing medical services.

Continuing to maintain its position as a reliable partner providing diverse and comprehensive equipment, materials, solutions, and services to customers; JVC sets the goal of legal safety and service quality on top, affirming the value: "Japanese quality - Real value", "Safe and sustainable development".

For products and services that have made up the JVC brand for more than 20 years, the Company will continue to focus and promote. At the same time, the Company will seek new product ranges, especially those related to intervention. This is a product line that brings practical benefits to patients, meaning that it contributes to high social security and is a trend in the world.

For associated investment and leasing activities, the Company will promote the implementation of new associated and leased business projects based on a comprehensive assessment of the legal corridor, efficiency, and development potential.

The company aims to enhance the quality of after-sales service through contracts for maintenance, and repair of medical equipment... bringing peace of mind and trust to customers. In addition, the Company will take advantage of a strong and skilled engineer force towards expanding the provision of technical services to customers in need to increase revenue and profits for the Company.

The JVC Board of Directors sets a target that Total consolidated revenue will reach VND 934 billion by 2028.

In addition, the General Meeting approved many important contents, including the addition of business registration lines and a plan to issue individual shares to investors.

The General Meeting also approved the election of Mr. Nguyen Van Chi to hold the position of an independent member of the Board of Directors of the Company for the term 2021 - 2026.